SciELO - Scientific Electronic Library Online

 
vol.52 issue2Potencial role of stem cell therapy in type 1 diabetes mellitus author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Arquivos Brasileiros de Endocrinologia & Metabologia

Print version ISSN 0004-2730

Abstract

BERTOLUCI, Marcello Casaccia; CE, Gislaine Vissoky; SILVA, Antônio Marcos V. da  and  PUNALES, Marcia K. C.. Endothelial dysfunction in type 1 diabetes. Arq Bras Endocrinol Metab [online]. 2008, vol.52, n.2, pp. 416-426. ISSN 0004-2730.  http://dx.doi.org/10.1590/S0004-27302008000200030.

Vascular complications are the main cause of mortality and morbidity in diabetes. Mechanisms involved in the development of micro and macrovascular disease are complex and partially understood, but invariably begin as a dysfunctional endothelium. Nitric oxide is an important regulator of endothelial function and the impairment of its activity is determinant of the endothelial dysfunction. In type 1 diabetes, many factors like acute, chronic and post-prandial hyperglycemia, as well as the duration of diabetes or autonomic neuropathy and microalbuminuria are associated to endothelial dysfunction. Oxidative stress, polyol pathway activation, protein kinase C activation and the presence of advanced glycation end-products are potential mechanisms involved in the development of endothelial dysfunction. Early detection of endothelial dysfunction has prognostic value for the development of vascular complications and may be important in strategies for primary prevention of cardiovascular endpoints in type 1 diabetes.

Keywords : Endothelial dysfunction; Type 1 diabetes; Nitric oxide; Atherosclerosis.

        · abstract in Portuguese     · text in Portuguese     · pdf in Portuguese